Lincoban

Advanced intramammary infusion, featuring 20 mg of Lincomycin, 20 mg of Neomycin, and Dexamethasone.

Specifically formulated to treat subacute, acute, or chronic mastitis in cattle.

For veterinarians considering an alternative first-choice intramammary treatment, Lincoban offers a compelling option. This formulation combines lincomycin and neomycin, providing a unique synergistic effect not found in other intramammary tubes. Lincomycin targets gram-positive bacteria effectively, while neomycin expands the spectrum to include some gram-negative pathogens. This dual-action approach makes Lincoban a logical and efficacious choice for treating mastitis, especially in cases where standard treatments may not be sufficient. By using Lincoban , vets can enhance treatment outcomes and improve herd health, ensuring better recovery for affected animals.

In lincomycin and neomycin combination, these have been found to have much higher efficacy than the sum of the two parts against Staphylococci aureus. It is effective against Gram positive and Gram negative pathogens, in particular staphylococcus, streptococcus and coliform bacteria.

Lincoban also contain dexamethasone which helps to alleviate the signs of edema, heat and pain, in addition to allowing a better diffusion of the antibiotics through inflamed tissues, decreasing the recovery time.

– Lactating cow intramammary solution for the treatment of mastitis.

– Can be used when cows with mastitis are milked once a day or twice a day.

– Contains both lincomycin and neomycin.

– Treats mastitis in cows, including typical pathogens.

– Easy to administer via intramammary administration.